Parian Global Management LP Cel Sci Corp Transaction History
Parian Global Management LP
- $30.8 Million
- Q3 2022
A detailed history of Parian Global Management LP transactions in Cel Sci Corp stock. As of the latest transaction made, Parian Global Management LP holds 50,000 shares of CVM stock, worth $465,500. This represents 0.35% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$465,500% of portfolio
0.35%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CVM
# of Institutions
13Shares Held
1.39MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY775KShares$7.21 Million0.0% of portfolio
-
Mai Capital Management526KShares$4.9 Million0.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL22.4KShares$208,9530.0% of portfolio
-
Raymond James & Associates St Petersburg, FL18.9KShares$175,7540.0% of portfolio
-
Hyperion Partners, LLC Berwyn, PA16.6KShares$154,5460.01% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $404M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...